Unknown

Dataset Information

0

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion.

ABSTRACT:

SUBMITTER: Zhang C 

PROVIDER: S-EPMC8637206 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown NAFLD-Associated HCC: Progress and Opportunities.
| S-EPMC8041650 | biostudies-literature
Unknown Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes.
| S-EPMC7398743 | biostudies-literature
Unknown A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
| S-EPMC8003582 | biostudies-literature
Unknown Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC.
| S-EPMC8073183 | biostudies-literature
Unknown The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma.
| S-EPMC8345138 | biostudies-literature
Unknown Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake.
| S-EPMC7206072 | biostudies-literature
Unknown Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC.
| S-EPMC7530304 | biostudies-literature
Unknown The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases.
| S-EPMC8235710 | biostudies-literature
Unknown ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy.
| S-EPMC6662851 | biostudies-literature
Genomics Defining treatment sensitivities in Myc related PDAC Subtypes
| PRJEB43040 | ENA